ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Ondine Biomedical Inc.

Ondine Biomedical Inc. (OBI)

9.00
0.00
(0.00%)
Closed January 05 10:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
9.00
Bid
8.50
Ask
9.50
Volume
118,335
8.85 Day's Range 9.00
4.50 52 Week Range 11.00
Market Cap
Previous Close
9.00
Open
9.00
Last Trade Time
Financial Volume
11,449p
VWAP
9.6752
Average Volume (3m)
462,100
Shares Outstanding
404,004,731
Dividend Yield
-
PE Ratio
-2.52
Earnings Per Share (EPS)
-0.04
Revenue
1.2M
Net Profit
-14.41M

About Ondine Biomedical Inc.

Sector
Biological Pds,ex Diagnstics
Industry
Minrls,earths-ground,treated
Website
Headquarters
Vancouver, British Columbia, Can
Founded
2004
Ondine Biomedical Inc. is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker OBI. The last closing price for Ondine Biomedical was 9p. Over the last year, Ondine Biomedical shares have traded in a share price range of 4.50p to 11.00p.

Ondine Biomedical currently has 404,004,731 shares outstanding. The market capitalization of Ondine Biomedical is £36.36 million. Ondine Biomedical has a price to earnings ratio (PE ratio) of -2.52.

OBI Latest News

Ondine Biomedical reports "exciting milestone" in US phase 3 trial

Ondine Biomedical Inc on Monday said it has recruited and treated the first patient in its phase 3 clinical trial eva ...

Ondine Biomedical Inc. Ondine recruits first patient for US Phase 3 trial

Ondine Biomedical Inc. 30 December 2024   ONDINE BIOMEDICAL INC.   ("Ondine Biomedical", "Ondine", or the "Company")   Ondine recruits first patient for US Phase 3 trial   Ondine Biomedical...

Ondine Biomedical Inc. Ondine commencing US Phase 3 clinical trial

Ondine Biomedical Inc. 17 December 2024   ONDINE BIOMEDICAL INC. ("Ondine Biomedical", "Ondine", or the "Company")   Ondine commencing US Phase 3 clinical trial   Ondine Biomedical Inc. (LON:...

Ondine Biomedical Inc. Notification of Major Holdings

Ondine Biomedical Inc. 25 November 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN CA68234M2058 Issuer Name ONDINE BIOMEDICAL INC UK or Non-UK Issuer...

Ondine Biomedical Inc. Notification of Major Holdings

Ondine Biomedical Inc. 22 November 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN CA68234M2058 Issuer Name ONDINE BIOMEDICAL INC UK or Non-UK Issuer...

Ondine Biomedical Inc. Director Holdings

Ondine Biomedical Inc. 22 November 2024   ONDINE BIOMEDICAL INC. ("Ondine Biomedical", "Ondine", or the "Company")   Director Holdings     Ondine Biomedical Inc. (LON: OBI), a Canadian life...

Ondine Biomedical Inc. NOTIFICATION OF MAJOR HOLDINGS

Ondine Biomedical Inc. 18 November 2024   Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing...

Ondine Biomedical Inc. Final Result of Fundraise & TVR

Ondine Biomedical Inc. 15 November 2024   THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN...

Ondine Biomedical Inc. Updated Result of Fundraise

Ondine Biomedical Inc. 14 November 2024   THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.55.882352941188.598.5645588.88630088DE
41.2516.12903225817.7597.551543608.21912535DE
122.62541.17647058826.3759.2564621008.12800551DE
261.2516.12903225817.759.255.6252586737.90529004DE
520.252.857142857148.75114.52944638.16543995DE
156-46.5-83.783783783855.555.54.515557112.11155695DE
260-47-83.928571428656594.515824213.91766959DE

OBI - Frequently Asked Questions (FAQ)

What is the current Ondine Biomedical share price?
The current share price of Ondine Biomedical is 9.00p
How many Ondine Biomedical shares are in issue?
Ondine Biomedical has 404,004,731 shares in issue
What is the market cap of Ondine Biomedical?
The market capitalisation of Ondine Biomedical is GBP 36.36M
What is the 1 year trading range for Ondine Biomedical share price?
Ondine Biomedical has traded in the range of 4.50p to 11.00p during the past year
What is the PE ratio of Ondine Biomedical?
The price to earnings ratio of Ondine Biomedical is -2.52
What is the cash to sales ratio of Ondine Biomedical?
The cash to sales ratio of Ondine Biomedical is 30
What is the reporting currency for Ondine Biomedical?
Ondine Biomedical reports financial results in CAD
What is the latest annual turnover for Ondine Biomedical?
The latest annual turnover of Ondine Biomedical is CAD 1.2M
What is the latest annual profit for Ondine Biomedical?
The latest annual profit of Ondine Biomedical is CAD -14.41M
What is the registered address of Ondine Biomedical?
The registered address for Ondine Biomedical is 888 - 1100 MELVILLE STREET, VANCOUVER, BRITISH COLUMBIA, V6E 4A6
What is the Ondine Biomedical website address?
The website address for Ondine Biomedical is ondinebio.com
Which industry sector does Ondine Biomedical operate in?
Ondine Biomedical operates in the MINRLS,EARTHS-GROUND,TREATED sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
igotthemojo igotthemojo 18 minutes ago
i am speaking as the foremost authority on kblb that there is...bar none...i am saying that this stock is ready to fly...and will start flying BEFORE Feb...i have spoken...
KBLB
nowwhat2 nowwhat2 21 minutes ago
The Total 3

https://investorshub.advfn.com/uimage/uploads/2025/1/5/twljxtotal_3_!_5_5d_1212am_whump.jpg



Sho nuff.......Whump......Much of this is XRP but I'll betcya Doge, etc. SOL, too

https://investorshub.advfn.com/uimage/uploads/2025/1/
XRPUSD
boi568 boi568 29 minutes ago
That spike to $31.50 was not organic and it was clearly generated by a big player. I have always thought it was an engineered mini-short squeeze.
AVXL
Mr. Bill Mr. Bill 41 minutes ago
https://www.goodrx.com/well-being/sleep/how-to-sleep-with-sciatica
nowwhat2 nowwhat2 42 minutes ago
Could still just be climbing in sympathy w overall crypto mkt

Scathingly poor outlooks

https://www.youtube.com/watch?v=EOsjnOUAw14



https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

WONDF
DonVance DonVance 44 minutes ago
This will hit 1k this year I believe now.
MSTR
georgejjl georgejjl 45 minutes ago
How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

The treatment used t
AVXL
Mr. Bill Mr. Bill 46 minutes ago
Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch
Graniteguy Graniteguy 47 minutes ago
Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of
AVXL
BDEZ BDEZ 49 minutes ago
The Russes hit the jackpot?
BDEZ BDEZ 50 minutes ago
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 50 minutes ago
Not good, thanks for sharing.
sand sand 57 minutes ago
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 58 minutes ago
Moving hard soon 
EFSH
mining101 mining101 59 minutes ago
Superb
MEGL
benz280c benz280c 1 hour ago
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 1 hour ago
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 1 hour ago
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 1 hour ago
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 1 hour ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 1 hour ago
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 1 hour ago
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 2 hours ago
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL

Your Recent History

Delayed Upgrade Clock